Actively Recruiting
Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
Led by Qianfoshan Hospital · Updated on 2025-02-28
134
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main purpose of this study is to investigate whether long-term oral administration of Staphylococcus albicans tablets can significantly reduce the number of acute exacerbations in patients with bronchiectasis. Secondary objective is to explore whether long-term oral administration of Staphylococcus albicans tablets can reduce the risk of hospitalization in patients with bronchiectasis and whether it can improve the quality of life of patients. Other purpose is to explore the regulatory effect of long-term oral administration of Staphylococcus albicans tablets on the immune function of patients with bronchiectasis.
CONDITIONS
Official Title
Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with bronchiectasis by clinical symptoms and chest HRCT
- Patients with idiopathic or post-infectious bronchiectasis
- Patients aged 18 years or older
- Patients who had at least 2 acute exacerbations of bronchiectasis in the year before enrollment
- Patients can be in either an acute exacerbation or stable phase at enrollment
You will not qualify if you...
- Diagnosis of cystic fibrosis
- Immunodeficiency or allergic bronchopulmonary aspergillosis
- Traction bronchiectasis caused by severe emphysema or advanced pulmonary fibrosis
- Current smokers
- Complicated with asthma or chronic obstructive pulmonary disease
- Severe cardiovascular, neurological, liver, or kidney diseases
- Malignant tumors
- Allergy to Staphylococcus albicans tablets
- History of gastric ulcer or intestinal malabsorption
- Pregnant or lactating women
- Poor compliance
- Use of immunostimulating drugs or immunosuppressants within 6 months before study start
- Participation in other interventional clinical trials within 3 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Respiratory, The First Affiliated Hospital of Shandong First Medical University
Jinan, Shandong, China, 250014
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here